Skip to content
10-Q

Quarterly Report

LEXICON PHARMACEUTICALS, INC. LXRX

0001062822-25-000054

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 4, 2025 363.4M sh
Shares Diluted Q3 2025 · Sep 30, 2025 363.4M sh
Shares Diluted Q3 2025 · Sep 30, 2025 362.93M sh
Shares Diluted Q3 2025 · Sep 30, 2024 361.49M sh
Shares Diluted Q3 2025 · Sep 30, 2024 306.11M sh
Capex Q3 2025 · Sep 30, 2025 $0
Capex Q3 2025 · Sep 30, 2024 $557K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$50.62M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$157.29M
Long Term Debt Q3 2025 · Sep 30, 2025 $56.51M
Long Term Debt Q3 2025 · Dec 31, 2024 $100.3M
Short Term Investments Q3 2025 · Sep 30, 2025 $66.29M
Short Term Investments Q3 2025 · Dec 31, 2024 $171.3M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $49.66M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $66.66M
Stockholders Equity Q3 2025 · Sep 30, 2025 $120.16M
Stockholders Equity Q3 2025 · Dec 31, 2024 $145.95M
Current Liabilities Q3 2025 · Sep 30, 2025 $21.72M
Current Liabilities Q3 2025 · Dec 31, 2024 $45.25M
Total Liabilities Q3 2025 · Sep 30, 2025 $85.77M
Total Liabilities Q3 2025 · Dec 31, 2024 $152.47M
Current Assets Q3 2025 · Sep 30, 2025 $122.53M
Current Assets Q3 2025 · Dec 31, 2024 $246.19M
Total Assets Q3 2025 · Sep 30, 2025 $205.93M
Total Assets Q3 2025 · Dec 31, 2024 $298.42M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.04
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.10
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.18
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.54
Eps Basic Q3 2025 · Sep 30, 2025 −$0.04
Eps Basic Q3 2025 · Sep 30, 2025 −$0.10
Eps Basic Q3 2025 · Sep 30, 2024 −$0.18
Eps Basic Q3 2025 · Sep 30, 2024 −$0.54
Sga Expense Q3 2025 · Sep 30, 2025 $7.6M
Sga Expense Q3 2025 · Sep 30, 2025 $28.56M
Sga Expense Q3 2025 · Sep 30, 2024 $39.59M
Sga Expense Q3 2025 · Sep 30, 2024 $110.84M
Rd Expense Q3 2025 · Sep 30, 2025 $18.76M
Rd Expense Q3 2025 · Sep 30, 2025 $49.81M
Rd Expense Q3 2025 · Sep 30, 2024 $25.78M
Rd Expense Q3 2025 · Sep 30, 2024 $57.8M
Net Income Q3 2025 · Sep 30, 2025 −$12.77M
Net Income Q3 2025 · Sep 30, 2025 −$34.81M
Net Income Q3 2025 · Jun 30, 2025 $3.25M
Net Income Q3 2025 · Mar 31, 2025 −$25.3M
Net Income Q3 2025 · Sep 30, 2024 −$64.81M
Net Income Q3 2025 · Sep 30, 2024 −$166.64M
Net Income Q3 2025 · Jun 30, 2024 −$53.43M
Net Income Q3 2025 · Mar 31, 2024 −$48.4M
Operating Income Q3 2025 · Sep 30, 2025 −$12.19M
Operating Income Q3 2025 · Sep 30, 2025 −$34.13M
Operating Income Q3 2025 · Sep 30, 2024 −$63.69M
Operating Income Q3 2025 · Sep 30, 2024 −$164.38M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $10K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $73K
Cost Of Revenue Q3 2025 · Sep 30, 2024 $71K
Cost Of Revenue Q3 2025 · Sep 30, 2024 $268K